Secret OUTLAST Dry Spray Antiperspirant Recalled for Benzene Contamination
Procter & Gamble is recalling Secret OUTLAST Dry Spray antiperspirant (3.8 oz) due to potential benzene contamination at the manufacturing facility. All lots expiring through September 2023 are affected.
What this means for you
Real risk of harm even if no illness or injury has been reported yet. Stop using the product and follow the agency's guidance.
Our severity reasoning: FDA Class II recall with chemical contamination hazard (benzene) at manufacturing facility. No hospitalization or reported illnesses are mentioned in the recall notice. Per the rubric, Class II recalls without reported illness fall to score 3.
Plain-English summary
Secret OUTLAST Dry Spray (3.8 oz / 107 g, NDC 69423-478-10) is being recalled by The Procter & Gamble Company due to a Current Good Manufacturing Practice (CGMP) deviation discovered at the manufacturing facility.
The recall was initiated because other lots produced at the same facility were found to be contaminated with benzene, a chemical substance that poses a potential health risk. The affected products include all lots with expiration dates through September 2023.
The product was distributed nationwide in the USA and Puerto Rico, as well as in Canada, Guam, Northern Mariana Islands, American Samoa, Bhutan, Timor-Leste, Maldives, Fiji, US Virgin Islands, Trinidad, Peru, Saint Marteen, Bahamas, Costa Rica, Guatemala, Honduras, Panama, Belize, Santa Lucia, Aruba, Dominican Republic, and Guyana.
Consumers who have purchased this product should stop using it and return it to the place of purchase or dispose of it safely.
The recalled product
- Product
- Secret OUTLAST Dry Spray, (Aluminum chlorohydrate 23.5%), Antiperspirant, Protecting Powder, Topical spray can 3.8 oz (107 g), Dist. by: Procter & Gamble, Cincinnati, OH 45202. NDC: 69423-478-10, UPC 0 37000 74772 7
- Manufacturer
- The Procter & Gamble Company
- Category
- Drug — Topical Antiperspirant
- Hazard
- benzene-contamination
- cgmp-deviation
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- All lots with expiry through September
- 2023
Distribution
Distributed nationwide across the United States.
Related recalls
Same category
- CriticalWarfarin Tablets Recalled After Mix-Up Between 2.5 mg and 5 mg Strengths
FDA (Drugs) · 2026-07-21
- ModerateFDA Recalls Pred Mild Ophthalmic Suspension Due to Failed Stability Specifications
FDA (Drugs) · 2026-06-03
- ModerateNicotine Transdermal System Patches Recalled for Oxidative Impurity Specification Failure
FDA (Drugs) · 2026-06-03
- LowPrimidone Tablets Recalled Due to Cross-Contamination with Acemetacin
FDA (Drugs) · 2026-05-27
- HighLiraglutide Injection Recalled Due to Particulate Matter in Cartridges
FDA (Drugs) · 2026-05-27